Cargando…
Genetic and epigenetic heterogeneity of epithelial ovarian cancer and the clinical implications for molecular targeted therapy
Epithelial ovarian cancer (EOC) is the most lethal gynaecological malignancy, and tumoural heterogeneity (TH) has been blamed for treatment failure. The genomic and epigenomic atlas of EOC varies significantly with tumour histotype, grade, stage, sensitivity to chemotherapy and prognosis. Rapidly ac...
Autores principales: | Bai, Huimin, Cao, Dongyan, Yang, Jiaxin, Li, Menghui, Zhang, Zhenyu, Shen, Keng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5125785/ https://www.ncbi.nlm.nih.gov/pubmed/26800494 http://dx.doi.org/10.1111/jcmm.12771 |
Ejemplares similares
-
Tumor heterogeneity in the recurrence of epithelial ovarian cancer demonstrated by polycomb group proteins
por: Gui, Ting, et al.
Publicado: (2014) -
Genome-wide DNA copy number analysis in clonally expanded human ovarian cancer cells with distinct invasive/migratory capacities
por: Li, Lei, et al.
Publicado: (2017) -
Salvage Chemotherapy for Patients With Recurrent or Persistent Ovarian Clear Cell Carcinoma: A Retrospective Study of 164 Cases
por: Bai, Huimin, et al.
Publicado: (2015) -
Characteristic and Prognostic Implication of Venous Thromboembolism in Ovarian Clear Cell Carcinoma: A 12-Year Retrospective Study
por: Ye, Shuang, et al.
Publicado: (2015) -
The proteomic comparison of peripheral circulation-derived exosomes from the epithelial ovarian carcinoma (EOC) patients and non-EOC subjects
por: Peng, Peng, et al.
Publicado: (2019)